Anti-V2 Antibody Deficiency in Individuals Infected with HIV-1 in Cameroon

The results of the RV144 vaccine clinical trial showed a correlation between high level of anti-V1V2 antibodies (Abs) and a decreased risk of acquiring HIV-1 infection. This turned the focus of HIV vaccine design to the induction of elevated levels of anti-V2 Abs to increase vaccine efficacy. In pla...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Virology
Main Authors: Liu, Lily, Li, Liuzhe, Nanfack, Aubin, Mayr, Luzia M., Soni, Sonal, Kohutnicki, Adam, Agyingi, Lucy, Wang, Xiao-Hong, Tuen, Michael, Shao, Yongzhao, Totrov, Maxim, Zolla-Pazner, Susan, Kong, Xian-Peng, Duerr, Ralf, Gorny, Miroslaw K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512328/
https://ncbi.nlm.nih.gov/pubmed/30665098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2019.01.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados